Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
about
Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogsDissecting Candida albicans Infection from the Perspective of C. albicans Virulence and Omics Approaches on Host-Pathogen Interaction: A ReviewNear-infrared laser adjuvant for influenza vaccineHuman recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherenceDecoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses.Wild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.Candida albicans proteinases and host/pathogen interactions.Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans.Adaptive immune responses to Candida albicans infection.Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins.Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine.Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection.Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c miceAn enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Evaluation of recombinant protein superoxide dismutase of Haemophilus parasuis strain SH0165 as vaccine candidate in a mouse model.Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes.In silico prediction and immunological validation of common HLA-DRB1-restricted T cell epitopes of Candida albicans secretory aspartyl proteinase 2.Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasisDivergence of Stp1 and Stp2 transcription factors in Candida albicans places virulence factors required for proper nutrient acquisition under amino acid control.Beyond the wall: Candida albicans secret(e)s to survive.Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infectionCandida albicans: Clinical Relevance, Pathogenesis, and Host Immunity
P2860
Q21563438-E1A6C333-1074-49EE-9E42-B826B4B4C197Q28067088-30391852-265D-4ADF-9A69-C6C9D3C9D19FQ28536886-DE9C0604-34F6-43A9-8ACA-8BD92A03B4D0Q30804794-2A2E3DEA-3CA5-410A-82E5-5D7D9D7DF324Q30862390-E0DBF611-5BBD-47DE-98F4-1E5191142ECCQ33224259-45AAD13A-E858-4FF8-A999-0657251F3A9FQ34081541-4EE4922D-C2F9-4B07-895D-D81D2CB8D888Q34301200-0AE9ACEF-3D3F-4B29-9E27-A9ACC3C49DB5Q35875741-D8B501FE-024F-470F-8109-B150BC231CFAQ36112280-D260A974-355B-4AF7-9648-8555C3F6B5ECQ36147114-0A494B21-B362-4855-8AFA-AB8A3208F79EQ36513475-9E593276-D0D5-4230-95F8-81F3AF6CC8E6Q36562397-E660D01B-74F2-400B-A738-9CA2FF1E2D1FQ36569737-62583652-ED28-4C35-9B2B-DF45C1F5F9FFQ36690302-1F4A03A7-92BB-43A6-A9FC-49A50BBDDCE8Q36788780-47FD01CB-4C37-45E5-9650-413B279920E1Q36977827-439840C7-D5D2-4CC9-8575-FCE0A5EB14F7Q37326963-6998CAD5-705C-43A1-95AD-41BDBD5A76E5Q37918556-3CE171C6-6944-4512-803D-39BA439ABDBCQ38759870-CE83CADC-4BE3-4840-A3DD-C488070B7AA1Q39906925-0C67BAA0-30E0-4AC2-9A99-190E95EF16D5Q42164312-F71311D4-41D1-426E-8B30-606DEC2CC315Q42375553-A041E907-6EFB-4A63-8D94-D005C7DEA72CQ42590211-392D543B-EB5F-4A3D-9F2F-4E8292D0E49EQ43992368-267EB717-ECBC-477A-982B-BC19924BF5F9Q55396489-0D12CA88-5F95-4427-B47E-44E2C598A75BQ59127572-97C14FFE-935B-40F3-A010-91DAAD544396Q59282466-FCAE31B7-D9A7-45D1-A6DE-E27F69811D4A
P2860
Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@en
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@nl
type
label
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@en
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@nl
prefLabel
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@en
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@nl
P2860
P50
P1433
P1476
Protection against systemic ca ...... ecreted aspartic proteinase 2.
@en
P2093
Andreia Marques
P2860
P304
P356
10.1111/J.1365-2567.2004.01819.X
P50
P577
2004-03-01T00:00:00Z